Article

Rethinking Alzheimer’s: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation Control

2025-03-11

Abstract excerpt

Alzheimer’s disease has traditionally been associated with amyloid-β plaques, but growing evidence underscores the role of neuroinflammation in disease progression. The autoimmune hypothesis of Alzheimer’s disease suggests chronic inflammation and immune dysfunction contribute to neuronal damage, making modulation of immune responses a promising therapeutic strategy for the disease. Cannabidiol, a phytocannabinoid...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e8727456-1de6-5580-88f1-249694240ea4
DOI: 10.1101/2025.03.06.641791

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rethinking Alzheimer’s: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation ControlDOI 10.1101/2025.03.06.641791Read

Cannabidiol and Alzheimer disease: A Comprehensive Review and In Silico Insights into Molecular InteractionsSemantic proximity Read

Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cellsSemantic proximity Read

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.Semantic proximity Read

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson´s diseaseSemantic proximity Read

Endocannabinoid Modulation of Microglial Phenotypes in NeuropathologySemantic proximity Read

Genetic Deletion of cyclooxygenase-1 ameliorates neuroinflammation and cognitive impairment in 5×FAD miceSemantic proximity Read

Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease.Semantic proximity Read

Sex-Dependent Altered Expression of Cannabinoid Signaling in Hippocampal Astrocytes of the Triple Transgenic Mouse Model of Alzheimer’s Disease: Implications for Controlling Astroglial ActivitySemantic proximity Read

Beyond Symptom Management: FAAH Inhibition as a Path to Mitigate Alzheimer’s Disease Progression in Mouse Models of AmyloidosisSemantic proximity Read

Systemic Inflammasome Activation and Pyroptosis Associate with the Progression of Alzheimer’s DiseaseSemantic proximity Read

Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathySemantic proximity Read

The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s DiseaseSemantic proximity Read